Neuronal loss has often been described at post-mortem in the brain neocortex of patients suffering from AIDS. Neuroinvasive strains of HIV infect macrophages, microglial cells and multinucleated giant cells, but not neurones. Processing of the virus by cells of the myelomonocytic lineage yields viral products that, in conjunction with potentially neurotoxic molecules generated by the host, might initiate a complex network of events which lead neurones to death. In particular, the HIV-1 coat glycoprotein, gp120, has been proposed as a likely aetiologic agent of the described neuronal loss because it causes death of neurones in culture. More recently, it has been shown that brain neocortical cell death is caused in rat by intracerebroventricular injection of a recombinant gp120 coat protein, and that this occurs via apoptosis. The latter observation broadens our knowledge in the pathophysiology of the reported neuronal cell loss and opens a new lane of experimental research for the development of novel therapeutic strategies to limit damage to the brain of patients suffering from HIV-associated dementia.
Cognitive impairment, postural disorders and tremor are among the most common symptoms encountered in patients suffering from HIV-associated dementia (HAD), a neurological syndrome described in some 20% of AIDS patients (Everall et al. 1994) . The neuropathological features of the brain described at post-mortem are myelin pallor, appearance of multinucleated giant cells, in®ltration by bloodderived macrophages, astroglial cell reaction and brain cortical neuronal cell loss (Everall et al. 1991; Price and Perry 1994) . The syndrome has been attributed to infection of the brain caused by the human immunode®ciency virus type 1 (HIV-1) because it is observed in patients free from opportunistic infections or concomitant cancer in the brain (Price and Perry 1994) , although neuroinvasive strains of HIV infect macrophages, microglial cells and multinucleated giant cells, but not neurones (Mucke et al. 1995) . Processing of the virus by cells of the myelomonocytic lineage yields host and viral products known to initiate a complex network of events, which may lead neurones to death and to the development of cerebral atrophy in AIDS patients (Gray et al. 2000) . In particular, the HIV-1 coat protein, gp120, has been proposed as a likely aetiologic agent of the described neuronal loss because it causes the death of neurones in culture (Lipton and Gendelman 1995) . More recently, brain cortical cell death has also been reported following intracerebroventricular injection of gp120 in rat, and this occurs via apoptosis.
Here, we summarize in vivo data supporting a role for the HIV coat protein, gp120, in the mechanisms of neuronal cell loss often described in the brain cortex of patients suffering from HAD (Everall et al. 1994) . gp120 causes apoptosis in the neocortex of rat Transgenic animals overexpressing gp120 in astrocytes display a pattern of neuropathological changes reminiscent of those described in subjects with AIDS, thus supporting a role for the HIV-1 coat protein in the pathophysiology of the associated neurological syndrome (Toggas et al. 1994) . Retardation in behavioural development has been described in neonatal rats treated systemically with gp120 (Glowa et al. 1992; Hill et al. 1993) , demonstrating that this is capable of causing cognitive impairment along with neuronal damage. More recently, Barks et al. (1997) have reported that in P7 neonatal rats focal injection of gp120 into the CA1 area of one dorsal hippocampus failed to produce, ®ve days later (P12), hippocampal atrophy, and also failed to cause neuronal damage other than a subtle focal pyramidal cell loss immediately adjacent to the injection track. In these animals, however, the same authors have shown that focal intrahippocampal co-injection of gp120 and NMDA brought the reduction of hippocampal volume caused by the latter excitotoxin from 19% to 26.4%; this effect was prevented by antagonists of the NMDA-receptor complex, thus providing direct evidence of neurotoxic synergism between the HIV-1 coat glycoprotein gp120 and excitatory amino acids in vivo in the immature brain, and con®rming that this interaction may occur at the level of the NMDA subtype of glutamate receptor (Barks et al. 1997) . Lack of gross hippocampal damage and of statistically signi®cant neuronal cell loss has been previously reported in adult rats receiving focal injection of gp120 (Bagetta et al. 1994a,b) , and this is in line with the data reported by Barks et al. (1997) . More recently, using the terminal-transferase (terminal¯uorescein 12-dUTP nick-end labeling, TUNEL) technique (Gavrieli et al. 1992) , we have shown the occurrence of DNA fragmentation in brain cortical tissue sections of adult rats receiving injections of the viral protein into one lateral cerebral ventricle (i.c.v.; Bagetta et al. 1995 Bagetta et al. , 1996a , suggesting that neuronal death caused by the HIV-1 coat protein may be of the apoptotic type. The latter deduction has been con®rmed by transmission electron microscopy (TEM) analysis of brain tissue sections obtained from rats treated with gp120 that revealed compaction and marginalization of nuclear chromatin along the inner surface of the nuclear envelope, and convolution of the nuclear margin in brain cortical cells (Bagetta et al. 1996b) (Fig. 1) , unequivocal signs of early and late apoptosis (Kerr et al. 1987) . In these animals, ultrastructural changes indicative of late apoptosis, such as masses of condensed chromatin and clumping of the nuclear envelope, have also been seen along with enlargement of the endoplasmic reticulum and normally Fig. 1 (a) Nucleus of a neurone from a control, BSA-treated rat (100 ng given i.c.v. once daily for seven consecutive days) with normally dispersed chromatin (Â6880). (b±d) Microphotographs showing apoptotic nuclei from the cortex of a rat receiving a single daily injection of gp120 (100 ng/day) for seven consecutive days. At low magni®-cation (Â540, b), two apoptotic nuclei (asterisks) and an injured cell with dilated nuclear envelope (arrows) can be seen. Chromatin aggregation, and pore dilation and clustering, typical of apoptotic cell death, are easely detectable at high magni®cation ( Â17 000). Note the change in mitochondrial integrity in (c) and endosplamic reticulum dilation in (d). Taken from Bagetta et al. (1996b) . appearing mitochondria.
Immunoelectronmicroscopy analysis of brain neocortical cells bearing ultrastructural features typical of apoptosis revealed that these are immunopositive for the neuro®lament (Fig. 2) , a typical neuronal marker (Bagetta et al. 1999) ; by contrast, glial ®brillary acidic protein (GFAP) immunopositive cells appeared normal, suggesting that under the present experimental conditions astroglial cells may not undergo apoptosis (data not shown; Bagetta et al. 1999) .
Neuronal apoptosis by gp120 was minimized in rats receiving (1 h beforehand) a single daily injection (0.25 pmoles given i.c.v. for seven consecutive days in all instances) of the b-chemokines RANTES, MIP-1a (natural ligands for the CCR5 chemokine receptor) or the a-chemokine SDF-1a (natural ligand for CXCR4 chemokine receptor) (Meucci and Miller 1999) ; likewise gp120, a higher dose (2.5 pmoles) of SDF-1a caused in situ DNA fragmentation (Corasaniti et al. 2000a) . Collectively, these data support the concept that neuronal and microglial mechanisms, downstream CCR5 and CXCR4 receptors, coreceptors for gp120 binding and HIV-1 penetration into macrophages and T cells, respectively (Meucci and Miller 1999) , may be responsible for neuronal apoptosis caused by the HIV-1 coat protein in the neocortex of rat.
gp120 causes abnormal expression of interleukin-1b in the neocortex
The mechanisms through which gp120 causes apoptosis in the brain of rat has yet to be discovered, although a series of recent experimental data does implicate the proin¯ammatory cytokine interleukin-1b (IL-1b). In fact, immunohistochemical and western blotting experiments show that treatment with gp120 enhances the expression of IL-1b in the neocortex, and double-labelling immunouorescence experiments have established that neuronal and, possibly, microglial cells are the main source of IL-1b (Bagetta et al. 1999) (Fig. 3) . Immunoelectron microscopy and enzyme-linked immunosorbent assay (ELISA) data have established that IL-1b is expressed, although at very low levels, in the mitochondria of brain neocortical cells of naive untreated rats; more importantly, subchronic administration (i.c.v.) of gp120 enhances the mitochondrial expression of the pro-in¯ammatory cytokine, and this implicates in situ activation of interleukin-converting enzyme (ICE) (Corasaniti et al. 2001) . In agreement with the latter deduction, antagonism studies have shown that combined treatment with gp120 and the inhibitor II (Ac-Tyr-Val-Ala-Asp-chloromethylketone) of ICE (Milligan et al. 1995) , the protease (also known as caspase 1) that processes pro-IL-1b in biologically mature IL-1b (Black et al. 1988; Kostura et al. 1989; Yuan et al. 1993; Walker et al. 1994; Martins and Earnshow 1997) , minimizes apoptotic cell death induced by the viral protein in the neocortex of rat (Bagetta et al. 1999) . Quite importantly, treatment with the antagonist of IL-1 receptor (IL-1ra), the receptor species that mediates most of the biological actions of IL-1b (Dripps et al. 1991; Hagan et al. 1996) , prevents apoptotic cell death caused by the viral protein (Corasaniti et al. 1998; Bagetta et al. 1999) and, likewise for gp120, subchronic i.c.v. administration of murine recombinant IL-1b causes apoptosis in the neocortex of rat (Bagetta et al. 1999) , further implicating this cytokine in the mechanism of gp120-induced neocortical cell death.
Cyclooxygenase-2 induction by gp120 triggers apoptosis via an excitotoxic, glutamate mediated, mechanism
The mechanism through which IL-1b mediates gp120-induced apoptosis in the neocortex of rat is not known. In the mammalian brain this pro-in¯ammatory cytokine represents a physiological signal for secretion of nerve growth factor (NGF), and this could enhance the survival of injured neurones (Strijbos and Rothwell 1995) . Interestingly, i.c.v. injections of gp120 enhanced IL-1b expression (Bagetta et al. 1999 ) but failed to elevate NGF production in the neocortex (Bagetta et al. 1996a) , and this might contribute, at least in part, to cell death (Bagetta et al. 1995 (Bagetta et al. , 1996b because of the lack of adequate trophic support (see Corasaniti et al. 1998 for further discussion).
It is well established that IL-1b can also affect the expression of inducible enzymes, such as nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), the terminal products of which may be highly cytotoxic (Merrill et al. 1993) . However, at variance with several in vitro data (Lipton and Gendelman 1995) , in rats treated with gp120 we failed to observe signi®cant changes in brain cortical citrulline (Bagetta et al. 1996a (Bagetta et al. , 1997 (Bagetta et al. , 1998a , the coproduct of NO synthesis (Knowles and Moncada 1994) . Although these data do negate the occurrence of excessive NO production in the neocortex of gp120-treated rats, it cannot be excluded that physiological levels of NO can interact with other radical species that may originate from activated brain cortical microglial cells (Bagetta et al. 1999) to produce peroxynitrite, known to spontaneously decompose to yield the hydroxyl radical, a species even more cytotoxic than NO and known to be involved in apoptosis (Coyle and Puttfarcken 1993) .
Instead, more recent data do support an important role for COX-2 in the mechanism of gp120-induced apoptosis. In fact, we have reported immunohistochemical evidence demonstrating that subchronic i.c.v. treatment with gp120 enhances the expression of COX-2 in the neocortex of rat (Bagetta et al. 1998b) . More importantly, a single dose of gp120 causes an increase of COX-2 expression, which is apparent 6 h after the injection of the viral protein (Fig. 4) , and this is paralleled by a signi®cant accumulation of prostaglandin E 2 (PGE 2 ) in the neocortex (Corasaniti et al. 2000b; Maccarrone et al. 2000) and a signi®cant increase in body temperature (Bagetta et al. 1999) in the rat.
Experimental evidence suggests that in the mammalian CNS, enhanced expression of COX-2, and accumulation of products of the arachidonic acid cascade, including tromboxan B 2 and PGE 2 , may be implicated in the pathophysiology of brain damage that follows exposure to Fig. 4 Ultrastructural evidence of apoptosis caused by the HIV-1 coat glycoprotein gp120 in a rat brain neocortical cell immunopositive for the neuro®lament, cytoskeletal, proteins and typical neuronal markers. Ultrathin tissue sections from the brain neocortex of a rat treated for seven consecutive days with a single daily dose (100 ng, given i.c.v.) of gp120 have been processed for electron microscopy detection of neuro®lament protein immunogold positive cells (see Bagetta et al. 1999 for antisera properties). In (a), the upper panel (11 000Â magni®cation) shows masses of condensed chromatin typical of late apoptosis; the lower panel shows, at a higher magni®cation (33 000Â) of the area indicated by the box in the upper panel, a typical ®lament distribution (see arrows) of alligned gold particles. In (b), the lower panel shows rare gold particles (see arrows; 13 000Â magni®cation). These are indistinguishable in the boxed area at lower magni®cation (6000Â) of the upper panel in a neocortical brain tissue section adjacent to the one shown in (a) and processed for negative control. Fig. 5 Schematic representation of a unifying hypothesis on the mechanisms underlying neuronal apoptosis induced by gp120 in the neocortex of rat. Administration of recombinant HIV-1 gp120 IIIB enhances neuronal and microglial expression of IL-1b (Bagetta et al. 1999) , an event that requires the conversion of the pro-IL-1b in the mature form of this cytokine via the intervention of interleukin converting enzyme (ICE) (Corasaniti et al. 2001) . IL-1b may enhance the expression of COX-2 (it is established that in the mammalian brain COX-2 is located in neuronal cells; Yamagata et al. 1993) to convert arachidonic acid (AA) into prostaglandin E 2 (PGE 2 ) which than accumulate (Bagetta et al. 1998b; Maccarrone et al. 2000) . Elevated PGE 2 stimulate Ca 21 -dependent release of glutamate from astrocytes (Bezzi et al. 1998 ) and this may be responsible for excitotoxic neuronal apoptosis in the neocortex of rat (Corasaniti et al. 2000a). excitotoxic stimuli (Gaudet et al. 1980; Fostermann et al. 1982; Baran et al. 1987; Seregi et al. 1987; Planas et al. 1995; Nogawa et al. 1997) . Therefore, it is conceivable that the observed abnormal expression of COX-2 and that accumulation of PGE 2 may be implicated in the mechanisms of apoptosis caused by gp120 in the neocortex of rat. In agreement with the latter hypothesis is the observation that apoptosis induced by gp120 is reduced by a systemic pretreatment with indomethacin (Bagetta et al. 1998b) , a speci®c but non-selective inhibitor of COX activities, and by NS398, a selective COX-2 inhibitor (Corasaniti et al. 2000a) . Under physiologic conditions, the level of expression of COX-2 gene product appears to correlate well with the state of activation of excitatory, glutamate-mediated, synaptic transmission (Yamagata et al. 1993) . In vitro and in vivo data suggest that gp120 enhances glutamate transmission via the release from astroglial cells of not yet well-identi®ed excitotoxins acting at the NMDA, but not non-NMDA, receptors in the mammalian brain (Lipton and Gendelman 1995) . Altogether, these data support the concept that the enhanced expression of COX-2 and the accumulation of PGE 2 observed here may be the consequence of abnormal activation of glutamate neurotransmission in the neocortex of gp120-treated rat. However, this does not appear to be the case because under our experimental conditions a systemic pretreatment with MK801, a selective antagonist of the NMDA receptor complex, failed to counteract gp120-enhanced COX-2 expression observed 6 h after treatment with the viral coat protein (Corasaniti et al. 2000a) (Fig. 4) . However, systemic pretreatment with competitive and noncompetitive NMDA receptor antagonists or with U-74389G, a free radical scavenger of the 21-aminosteroid family, reduced gp120-induced apoptosis in the neocortex of rat (Corasaniti et al. 2000b) , supporting an excitotoxic glutamate-mediated mechanism of death (Choi 1988) . Bezzi et al. (1998) have previously demonstrated that products of the arachidonic acid cascade (PGE 2 being among the most potent) stimulate the Ca 21 -dependent release of glutamate from astroglial cells, leading to the suggestion that this mechanism may have physiological as well as pathophysiological consequences in the mammalian brain. Therefore, to rationalize the observed lack of MK801 effect on COX-2 expression with the neuroprotection afforded by the NMDA receptor antagonists and by the 21-aminosteroid, U-74389G, we suggest that IL-1b may be responsible for the gp120-evoked rapid induction of COX-2 and accumulation of PGE 2 , which may elevate, possibly through a mechanism similar to that described by Bezzi et al. (1998) , synaptic glutamate; this would then trigger a vitious loop leading the cell to oxidative stress and apototic death via an excitotoxic mechanism (Choi 1988) . The series of events initiated by gp120 and leading to apoptotic cell death are schematically reported in Fig. 5 .
In conclusion, the observation that gp120 induces apoptotic cell death in the rat neocortex in vivo, together with the recent evidence of DNA fragmentation reported at post-mortem in the brain of AIDS patients (Petito and Roberts 1995) , suggests that this mechanism may underlie the well-established cortical neuronal loss described in the brain of AIDS patients. The recent immunolocalization of gp120 in human brain tissue with the neuropathological correlates of HIV-1 encephalitis and pre-mortem diagnosis of HAD provides the missing link in the understanding of HIV neuropathogenisis (Jones et al. 2000) ; gp120 may, in fact, be present in suf®cient quantity during HIV infection to cause neuronal damage (Jones et al. 2000) , although other viral components, such as Tat, may also contribute (Bansal et al. 2000) .
Here, we would like to speculate that con®rmation of the neuroin¯ammatory steps we have partly dissected in the brain of gp120-treated rats may prove useful for the study of the underlying pathophysiological mechanisms of neuronal death. Finally, demonstration at the ultrastructural level of the occurrence of apoptosis in the brain cortex of AIDS patients will validate the usefulness of the rat model we have developed for the characterization of the neuroprotective pro®le of drugs that interfere with mediators of neuroin¯ammation and the crucial steps involved in the activation of the death programme.
